10.23USD+1.99%Mkt Cap: 609.77M USDP/E: 5.13Last update: 2026-05-26
Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platf…
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap609.77M USD
Enterprise Value420.65M USD
Revenue (TTM)122.29M USD
Gross Profit89.99M USD
Net Income (TTM)83.23M USD
Revenue/Share2.169 USD
Last Price10.23 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees61
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)5.13
P/E (Forward)5.48
PEG10.67
EV/EBITDA33.03
EV/Revenue3.44
P/S5.07
P/B3.86
EPS (TTM)2.01
EPS (Forward)1.92
52W Range
7.16051% of range13.16
52W High13.16 USD
52W Low7.160 USD
Profitability
Gross Margin84.52%
Oper. Margin24.38%
EBITDA Margin10.41%
Profit Margin78.17%
ROE53.82%
ROA29.23%
Growth
Revenue Growth77.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.60M USD
CapEx (TTM)835.00K USD
FCF Margin21.14%
FCF Yield4.24%
Net Debt-199.47M USD
Net Debt/EBITDA-15.66
Balance Sheet
Debt/Equity0.41
Current Ratio4.89
Quick Ratio4.74
Book Value/Sh2.720 USD
Cash/Share3.394 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateDec 28, 2020
Splits
Last Split1:16
Split DateDec 28, 2020
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)23.00 USD
Target Range18.00 USD – 26.00 USD
# Analysts9
Ownership
Shares Out.59.12M
Float54.96M
Insiders1.40%
Institutions70.62%
Short Interest
Short Ratio6.5d
Short % Float8.52%
Short % Out.8.43%
Shares Short4.98M
Short (prev mo.)4.44M
Technical
SMA 5010.06 (+1.7%)
SMA 2009.411 (+8.7%)
Beta0.88
S&P 52W Chg28.31%
Avg Vol (30d)1.37M
Avg Vol (10d)2.01M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—